Pages that link to "Q37347099"

The following pages link to Anti-angiogenic targets in the treatment of advanced renal cell carcinoma (Q37347099):

Displaying 19 items.

• ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma (Q28479196) (← links)
• Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review (Q31010355) (← links)
• Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy (Q33422258) (← links)
• Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma (Q35623092) (← links)
• Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape (Q37066106) (← links)
• Targeting the Met signaling pathway in renal cancer. (Q37331862) (← links)
• Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations (Q37546055) (← links)
• Growth factors as active participants in carcinogenesis: a perspective (Q37676697) (← links)
• Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma (Q37926019) (← links)
• TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma. (Q38927716) (← links)
• Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism (Q39474898) (← links)
• VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma (Q42026232) (← links)
• Pazopanib (Q43204474) (← links)
• Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma (Q44071439) (← links)
• Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma (Q46671264) (← links)
• Course of size and density of metastatic renal cell carcinoma lesions in the early follow-up of molecular targeted therapy (Q47359310) (← links)
• Pazopanib for the Treatment of Non-Clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study (Q48792840) (← links)
• The Role of Angiogenesis in Cancer Treatment (Q50932310) (← links)
• MRI with magnetic nanoparticles monitors downstream anti-angiogenic effects of mTOR inhibition. (Q54667186) (← links)